Skip to main content
. 2020 Nov 5;62(2):74–78. doi: 10.1111/j.1875-595X.2011.00092.x

Table 1.

Demographic and clinical features

Variable Group 1 (placebo) Group 2 (dexamethasone) Group 3 (morphine)
(n = 30) (n = 30) (n = 30)
Gender (%)
Male 36.7 30 33.3
Female 63.3 70 66.7
Pulp status (%)
Vital 80 80 73.3
Nonvital 20 20 26.7
Teeth (%)
Upper 60 53.3 50
Lower 40 46.7 50
Presence of pretreatment pain (%) 100 96.7 96.7
Presence of periapical radiolucency (%) 20 26.7 23.3